07/08/2014 - 4:26pm
Rite Aid enters fifth Health Alliance partnership

Rite Aid and Heritage Provider Network last month announced a new agreement to bring the Rite Aid Health Alliance program to HPN's chronic and polychronic patients in Southern California.

07/08/2014 - 3:30pm
Latest evolution of RAD Wellness ‘90210-worthy’ - Part 1

Rite Aid celebrated the latest evolution of its Wellness store format, with a June 23 grand opening truly befitting of its 90210 address.

07/31/2014 - 1:25pm
Dr. Reddy's announces Q1 2015 results

Dr. Reddy's Labs announced financial results for the quarter ended June 30, which includes consolidated revenues of Rs.35.2 billion, representing year-on-year growth of 24%.

07/31/2014 - 12:05pm
FDA to publish fiscal year 2015 generic drug user fee rates

The Food and Drug Administration on Friday will publish the fiscal year 2015 generic drug user fee rates as required under the Food Drug and Cosmetic Act as amended by the Generic Drug User Fee Amendments of 2012.

07/31/2014 - 10:56am
Generic medicine revenue up 5% for Teva's Q2

Teva Pharmaceuticals on Thursday announced results for second quarter 2014, which included revenues of $5 billion, an increase of 2% compared to the same period last year.

07/31/2014 - 9:16am
CVS/pharmacy earns first-ever URAC Community Pharmacy accreditation

CVS/pharmacy and URAC have announced that CVS/pharmacy is the first pharmacy in the nation to earn the new Community Pharmacy accreditation from URAC, a healthcare accreditation organization that establishes quality standards for the health care industry. All CVS/pharmacy and Longs Drug Store locations nationwide have earned this accreditation.

07/31/2014 - 8:17am
McKesson's Q1 up 37% to $44.1 billion

McKesson on Thursday reported revenues of $44.1 billion for the first quarter ended June 30, up 37%. 

07/30/2014 - 2:34pm
Pfizer acquires Baxter International vaccine portfolio for $635 million

Pfizer on Wednesday announced that it has entered into a definitive agreement to acquire Baxter International’s portfolio of marketed vaccines for $635 million.

07/30/2014 - 10:58am
Perrigo announces first-to-file patent challenge

Perrigo on Wednesday announced that it has filed an abbreviated new drug application with the Food and Drug Administration for desoximetasone topical spray 0.25%. The company also has notified Taro Pharmaceuticals U.S.A., the owner of the reference listed drug, of the filing.

07/30/2014 - 10:32am
Tanzeum now available in U.S. pharmacies

GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.